Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate increases intestinal carnitine absorption in rats

Pharmacological Research

Volumn 58, Issue 1, 2008, Pages 58-64

  Ringseis, Robert ^a   Lüdi, Silvia ^a   Hirche, Frank ^a   Eder, Klaus ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Clofibrate; Intestinal carnitine absorption; OCTN2; PPAR activation; Rat; Small intestine

Indexed keywords

ACYL COENZYME A OXIDASE; AMINO ACID TRANSPORTER; AMINO ACID TRANSPORTER ATB0+; CARNITINE; CLOFIBRATE; MESSENGER RNA; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SMALL INTESTINE ABSORPTION; SPRAGUE DAWLEY RAT; UPREGULATION;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; ANTILIPEMIC AGENTS; CARNITINE; CARRIER PROTEINS; CLOFIBRATE; DIET; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIVER; MALE; MEMBRANE PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 50649085921     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.06.006     Document Type: Article

References (42)

1. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244 (1997) 1-14
2. Steiber A., Kerner J., and Hoppel C.L. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25 (2004) 455-473
3. Rebouche C.J., and Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18 (1998) 39-61
4. Lohninger A., Pittner G., and Pittner F. l-Carnitine: new aspects of a known compound-a brief survey. Chem Monthly 136 (2005) 1255-1268 10.1007/s00706-005-0339-2
5. Vaz F.M., and Wanders R.J. Carnitine biosynthesis in mammals. Biochem J 361 (2002) 417-429
6. Van Vlies N., Wanders R.J.A., and Vaz F.M. Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: differences between the mouse and the rat. Anal Biochem 354 (2006) 132-139
7. Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419 (1997) 107-111
8. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273 (1998) 20378-20382
9. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275 (2000) 40064-40072
10. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., et al. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15 (1996) 5336-5348
11. Luci S., Geissler S., König B., Koch A., Stangl G.I., Hirche F., et al. PPARα agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 350 (2006) 704-708
12. Ringseis R., Pösel S., Hirche F., and Eder K. Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacol Res 56 (2007) 175-183
13. van Vlies N., Ferdinandusse S., Turkenburg M., Wanders R.J., and Vaz F.M. PPARα-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim Biophys Acta 1767 (2007) 1134-1142
14. Koch A., König B., Stangl G.I., and Eder K. PPARα mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Exp Biol Med (Maywood) 233 (2008) 356-365
15. Taylor P.M. Absorbing competition for carnitine. J Physiol 532 (2001) 283
16. Yokogawa K., Higashi Y., Tamai I., Nomura M., Hashimoto N., Nikaido H., et al. Decreased tissue distribution of l-carnitine in juvenile visceral steatosis mice. J Pharmacol Exp Ther 289 (1999) 224-230
17. 0+ from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol 532 (2001) 297-304
18. National Research Council. Guide for the care and use of laboratory animals. Publication no. 85-23 (rev.). Washington, DC: National Institutes of Health; 1985.
19. Reeves P.G., Nielsen F.H., and Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
20. 2 im Darminhalt und Kot nach Kjehldahlauschluß. Arch Anim Nutr 37 (1987) 453
21. Hafez S., Junge W., and Kalm E. Estimate of digestibility in dairy cows using an indicator method in comparison to the Hohenheimer feed value test. Arch Anim Nutr 38 (1988) 929-945
22. Fournier P., and Dupuis Y. A method of indirect evaluation of the titer of absorption of phosphorus compounds at different levels of the digestive tract. J Physiol (Paris) 45 (1953) 443-449
23. Jagger S., Wiseman J., Cole D.J.A., and Craigon J. Evaluation of inert markers for the determination of ileal faecal apparent digestibility values in the pig. Br J Nutr 68 (1992) 729-739
24. Kane E.A., Jacobson W.C., and Moore L.A. A comparison of techniques used in digestibility studies with dairy cattle. J Nutr 41 (1950) 583-596
25. - Δ Δ Ct method. Methods 25 (2001) 402-408
26. Koch A., König B., Luci S., Stangl G.I., and Eder K. Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats. Br J Nutr 98 (2007) 882-889
27. Rebouche C.J., Bosch E.P., Chenard C.A., Schabold K.J., and Nelson S.E. Utilization of dietary precursors for carnitine synthesis in human adults. J Nutr 119 (1989) 1907-1913
28. Li B.U., Bummer P.M., Hamilton J.W., Gudjonsson H., Zografi G., and Olsen W.A. Uptake of l-carnitine by rat jejunal brush border microvillous membrane vesicles. Evidence of passive diffusion. Dig Dis Sci 35 (1990) 333-339
29. Gross C.J., and Henderson L.M. Absorption of d- and l-carnitine by the intestine and kidney tubule in the rat. Biochim Biophys Acta 772 (1984) 209-219
30. Shaw R.D., Li B.U., Hamilton J.W., Shug A.L., and Olsen W.A. Am J Physiol 245 (1983) G376-G381
31. Slitt A.L., Cherrington N.J., Hartley D.P., Leazer T.M., and Klaassen C.D. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30 (2002) 212-219
32. Kato Y., Sugiura M., Sugiura T., Wakayama T., Kubo Y., Kobayashi D., et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70 (2006) 829-837
33. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91 (1994) 7355-7359
34. Lahjouji K., Mitchell G.A., and Qureshi I.A. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab 73 (2001) 287-297
35. Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N., et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21 (1999) 91-94
36. Wu X., George R.L., Huang W., Wang H., Conway S.J., Leibach F.H., et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466 (2000) 315-327
37. Lamhonwah A.M., and Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345 (2006) 1315-1325
38. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15 (1995) 3012-3022
39. Choudhury A.I., Chahal S., Bell A.R., Tomlinson S.R., Roberts R.A., Salter A.M., et al. Species differences in peroxisome proliferation; mechanisms and relevance. Mutat Res 448 (2000) 201-212
40. Bremer J. Carnitine-metabolism and functions. Physiol Rev 63 (1983) 1420-1480
41. Yoon H.R., Hong Y.M., Boriack R.L., and Bennett M.J. Effect of l-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats. Pediatr Res 53 (2003) 788-792
42. Maccari F., Arseni A., Chiodi P., Ramacci M.T., Angelucci L., and Hulsmann W.C. l-Carnitine effect on plasma lipoproteins of hyperlipidemic fat-loaded rats. Lipids 22 (1987) 1005-1008